This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elizabeth Trotta

Staff Reporter

Elizabeth Trotta joined TheStreet.com in 2007 after reporting on exchanges for Investment Dealers' Digest. Prior to that, she was a writer and associate editor with Advanstar Communications covering business management topics for Veterinary Economics and Firstline Magazine. She also held internships writing for Vance Publishing and PilgrimPage and was a graduate research assistant at KU. She has a B.A. in English and a B.S. and M.S. in journalism from the University of Kansas.

Elizabeth Trotta
By This Author:
« Back
Page 1 of 1
Next »

Big Board Breakdown: Non-Stress Test News

By Elizabeth Trotta

Alix Steel and Liz Trotta break down the top headlines of the day including same store sales results and General Motors

03:38PM 05/07/09

Stress Test Rumors

By Elizabeth Trotta

Alix Steel and Liz Trotta round up today's stress tests rumors and break down any possible surprises after Thursday's results

04:11PM 05/06/09

Top Ten Most Searched Stocks on TheStreet.com

By Elizabeth Trotta

Liz Trotta Details The Most Popular Searched Stocks On TheStreet.com.

04:17PM 02/12/09

Amgen Builds Body of Evidence for Bone Drug

By Elizabeth Trotta

Elizabeth Trotta talks to Glenn Begley, vice president for hematology oncology research at Amgen, about potential blockbuster bone drug denosumab.

12:00PM 11/25/08

Merck's Surprising Settlement

By Elizabeth Trotta

Elizabeth Trotta, pharmaceuticals reporter for TheStreet.com, discusses Merck's unexpected Vioxx settlement.

11:26AM 11/09/07

« Back
Page 1 of 1
Next »

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,719.00 +33.27 0.19%
S&P 500 2,052.75 +4.03 0.20%
NASDAQ 4,701.8670 +26.1550 0.56%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs